A nurse is caring for a client who is taking lithium and reports starting a new exercise program. The nurse should assess the client for which of the following electrolyte imbalances?

A. Constipation: Constipation is not a commonly reported adverse effect of clopidogrel.

Therefore, it is not necessary to instruct the client to monitor and report constipation as an adverse effect.
B. Weight loss: Weight loss is not a commonly reported adverse effect of clopidogrel. Therefore, it is not necessary to instruct the client to monitor and report weight loss as an adverse effect.
C. Bruising: Clopidogrel is an antiplatelet medication that inhibits platelet aggregation.

Therefore, one of the potential adverse effects is an increased risk of bleeding, which can

manifest as easy bruising or prolonged bleeding from minor injuries. Instructing the client to monitor and report bruising is important for early detection of bleeding complications.
D. Blurred vision: Blurred vision is not a commonly reported adverse effect of clopidogrel.

Therefore, it is not necessary to instruct the client to monitor and report blurred vision as an adverse effect.

A. To assess compatibility of the verapamil with newly ordered medications: Verapamil is a calcium channel blocker used to treat hypertension, angina, and arrhythmias. It has potential interactions with many other medications due to its effects on cardiac conduction and blood
pressure. Therefore, consulting the pharmacist is important to assess compatibility and potential drug interactions when new medications are prescribed.
B. To request a change in the dosage of the verapamil: Changing the dosage of verapamil may require a healthcare provider's order rather than consultation with a pharmacist.
C. To verify the frequency of administration of the verapamil: The frequency of administration of verapamil is typically determined by the healthcare provider and documented in the prescription. The pharmacist's role may involve dispensing the medication as prescribed but not verifying the frequency unless there are discrepancies.
D. To report the client's refusal to take the verapamil: Reporting the client's refusal to take the medication should be communicated to the healthcare provider for further assessment and
intervention. The pharmacist's role is primarily related to medication dispensing and ensuring appropriate use rather than addressing client refusals.